SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-137754
Filing Date
2024-05-14
Accepted
2024-05-14 08:30:32
Documents
15
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d799934d8k.htm   iXBRL 8-K 25905
2 EX-99.1 d799934dex991.htm EX-99.1 81958
6 GRAPHIC g799934dsp005.jpg GRAPHIC 3683
  Complete submission text file 0001193125-24-137754.txt   246878

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20240514.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20240514_lab.xml EX-101.LAB 17910
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20240514_pre.xml EX-101.PRE 11238
18 EXTRACTED XBRL INSTANCE DOCUMENT d799934d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 24941561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)